(CNN) The US Food and Drug Administration has issued a warning letter to the Canadian company CanaRx for playing a role in "the introduction of unapproved new drugs and misbranded drugs" to the United States, according to the letter. A misbranded drug fails to bear either adequate directions for its intended use or adequate warnings relating to its use. "CanaRx believes that the FDA is trying to prevent Americans from being injured by unregulated suppliers of counterfeit and other dangerous substances. The FDA letter warns that those are serious medical conditions and that side effects of drugs that may have been recalled, but still obtained through CanaRx, could be life-threatening. The warning letter calls for CanaRx to "promptly cease causing the distribution of unapproved new drugs and misbranded drugs to U.S. consumers and correct all other violations."

Source: CNN March 01, 2019 18:58 UTC